Keywords: novartis, anti-ige, antibody, cuts, hay, fever, symptoms

Novartis anti-IgE antibody cuts hay fever symptoms

Article | 17 May 1999

Phase III results with Xolair (rhuMAb-E25), an anti-immunoglobulin Eantibody developed by Genentech and Tanox and licensed to Novartis, have shown ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genentech

Novartis

Go to company listing

Related Drugs

Omalizumab

Xolair

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing